A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod

Nils Koch-Henriksen*, Melinda Magyari, Finn Sellebjerg, Per Soelberg Sørensen

*Corresponding author af dette arbejde
32 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab